Related Experiment Video
Updated: Oct 11, 2025

14:24
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
11.8K
Perimyocarditis Following COVID-19 Vaccination
Mariana Tinoco1, Sérgio Leite1, Bebiana Faria1
1Hospital da Senhora da Oliveira, Guimarães, Portugal.
Clinical Medicine Insights. Cardiology
|December 6, 2021
Summary
A man developed perimyocarditis, a heart inflammation, after his second Pfizer-BioNTech COVID-19 vaccine dose. This case highlights potential cardiovascular complications following COVID-19 vaccination.
Area of Science:
- Cardiology
- Immunology
- Vaccinology
Background:
- The widespread administration of COVID-19 vaccines has led to extensive monitoring for adverse events.
- While generally safe, rare adverse events associated with vaccines require thorough investigation.
Observation:
- A 39-year-old male presented with chest pain three days post-Pfizer-BioNTech COVID-19 vaccination.
- Initial investigations revealed elevated cardiac biomarkers (troponin, C-reactive protein).
Findings:
- Cardiac MRI confirmed myocardial edema and inflammation, diagnosing perimyocarditis.
- The condition was deemed a likely consequence of the COVID-19 vaccination, with other causes ruled out.
Implications:
- This case underscores the importance of considering cardiac complications, such as perimyocarditis, following COVID-19 vaccination.
- Healthcare providers should maintain awareness of potential cardiovascular side effects to ensure timely diagnosis and management.
Related Concept Videos
Myocarditis III: Medical Management
30
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
30
Myocarditis II: Clinical Features and Diagnostic Tests
41
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
41
Myocarditis I: Introduction
62
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
62
Pericarditis I: Introduction
39
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
39
Myocarditis IV: Nursing Management
56
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
56
Pericarditis III: Medical Management
56
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
56

